期刊文献+

S100A4基因在不同骨肉瘤细胞和组织中的表达 被引量:2

Expression of S100A4 gene on different osteosarcoma cell lines and tissues
下载PDF
导出
摘要 [目的]检测S100A4基因在人骨肉瘤细胞系MG-63、U-2OS以及骨肉瘤组织中的表达情况并分析其临床意义。[方法]应用Real-time PCR方法检测S100A4基因在人骨肉瘤细胞MG-63及U-2OS中的表达,用免疫组织化学SP法检测骨肉瘤S100A4、CD44V6蛋白表达,并分析二者的关系。[结果]人骨肉瘤细胞系MG-63及U-2OS中均有S100A4基因表达;S100A4蛋白在骨肉瘤组织中表达的阳性率是69.7%,表达位置在骨肉瘤细胞的细胞浆,CD44V6蛋白在骨肉瘤组织中表达的阳性率是60.6%,表达位置在骨肉瘤和骨软骨瘤细胞均为细胞膜和近膜胞浆,二者的表达呈正相关(r=0.413,P<0.05)。[结论]S100A4基因在不同的骨肉瘤组织及其细胞系均有较高水平表达,其表达可能在侵袭和转移中发挥作用。 [ Objective] To detect the expression of S100A4 gene in human osteosarcoma MG-63 and U -2OS cell lines and the expressions of S100A4 and CD44V6 in osteosarcoma tissues, and then analyze its clinical significance. [ Meth- ods ] The expressions of S100A4 gene in human osteosarcoma MG -63 and U -2OS cell lines were detected by real -time PCR. The protein expressions of S100A4 and CD44V6 were detected by immunohistochemistry SP method, and anlyzed the relationship between both things. [ Results~ The result of real - time PCR showed that human osteosarcoma cell lines of MG- 63 and U -2OS had the expression of S100A4 gene. The positive rate of S100A4 protein expression in osteosarcoma tissues was 69.7%, and the expression located in cytoplasm. The positive rate of CI)44V6 protein expression in osteosarco- ma tissues was 60.6% , and the expression of CD44V6 located at cell membrane and cytoplasm near the cell membrane of osteosarcoma cells and osteochondroma cells. The expression of S100A4 was positively related to that of CD44V6 in osteo- sarcoma tissues (r = 0. 413, P 〈 0.05 ). [ Conclusion] S100A4 gene expresses in human osteosarcoma cells in vitro and in vivo. S100A4 might play a role in invasion and metastasis of osteosarcoma.
出处 《大连医科大学学报》 CAS 2011年第6期542-545,共4页 Journal of Dalian Medical University
关键词 骨肉瘤 S100A4 CD44V6 osteosarcoma S100A4 CD44V6
  • 相关文献

参考文献12

  • 1Boye K,Maelandsmo GM.S100A4 and metastasis:a small actor playing many roles[J].Am J Pathol,2010,176(2):528-535.
  • 2Shebet GV.Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy[J].Cancer Lett,2009,280 (1):15-30.
  • 3Rosty C,Ueki T,Argani P,et al.Over expression of S100A4 in pancreatic ductal adenocar-cinomas is associated with poor differentiation and DNA hypomethylation[J].Am J Pathol,2002,160 (1):45-50.
  • 4Davies BR,ODonnell M,Durkan GC,et al.Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer[J].J Pathol,2002,196 (3):292-299.
  • 5Levett D,Flecknell PA,Rudland PS,et al.Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer[J].Am J Pathol,2002,160(2):693-700.
  • 6Kohya N,Kitajima Y,Jiao W,et al.Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line:repression of MTS1/S100A4 gene expression[J].Int J Cancer,2003,104:44-53.
  • 7Andersen K,Nesland JM,Holm R,et al.Expression of S100A4combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma[J].Mod Pathol,2004,17 (8):990-997.
  • 8Tanaka S.Targeting CD44 in mast cell regulation[J].Expert Opin Ther Targets,2010,14 (1):31-43.
  • 9Forst B,Hansen MT,Klinqelhofer J,et al.Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice[J].PLos One,2010,5 (4):e10374.
  • 10Jeon CH,Kim HL,Park JH.Induction of S100A4,S100A6,and galectin-1 during the lineage commitment of CD4 + CD8+ thymocyte cell line is suppressed by 2,3,7,8-tetrachlorodibenzo-p-dioxin[J].Toxicol Lett,2009,187(3):157-163.

同被引文献21

  • 1Foshay KM,Gallicano GI.Small RNAs,big potential:the role of MicroRNAs in stem cell function[J].Curr Stem Cell Res Ther,2007,2 (4):264-271.
  • 2Micklem DR,Lorens JB.RNAi screening for therapeutic targets in human malignancies[J].Curr Pharm Biotechnol,2007,8 (6):337-343.
  • 3Ying SY,Chang DC,Lin SL.The microRNA (miRNA):overview of the RNA genes that modulate gene function[J].Mol Biotechnol,2008,38 (3):257-268.
  • 4Donato R.S100:a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles[J].Int J Biochem Cell Biol,2000,33 (7):637-668.
  • 5Boye K,Andersen K,Tveito S,et al. Interferongamma-induced suppression of S100A4 transcription is mediated by the class Ⅱ transactivator[J].Tumour Biol,2007,28 (1):27-35.
  • 6Tarabykina S,Griffiths TR,Tulchinsky E,et al.Metastasis-associated protein S100A4:spotlight on its role in cell migration[J].Curr Cancer Drug Targets,2007,7 (3):217-228.
  • 7ALLEN K D, GOLIGHTLY Y M. Epidemiology of osteoarthritis: state of the evidence[J]. Current Opinion in Rheumatology, 2015, 27(3): 276 283.
  • 8HEIJINK A, GOMOLL A H, MADRY H, et al. Biomechanical considerations in the pathogenesis of osteoarthritis of the knee[J]. Knee Surgery Sports Traumatology Arthroscopy, 2015, 20(3): 1-6.
  • 9JOERN W-P M, SCHL[JTER-BRUST K U, PEER E. The epi- demiology, etiology, diagnosis, and treatment of osteoarthritis of the knee[J]. Deutsches )~rzteblatt International, 2010, 107(9): 152- 162.
  • 10ROSENZWEIG D H, QUINN T M, HAGLUND L. Low-frequency high-magnitude mechanical strain of articular chondrocytes acti- vates p38-MAPK and induces phenotypic changes associated with osteoarthritis and pain[J]. International Journal of Molecular Sci- ences, 2014, 15(8): 14427-14441.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部